Japan Tobacco Inc (2914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Japan Tobacco Inc (JT Group) is a tobacco company. Its primary activities include the manufacture and sale of tobacco products and production of processed foods. The company's major products comprise a wide range of tobacco brands, frozen noodles, prescription drugs, packaged cooked rice, seasonings, and frozen and ambient processed foods. JT Group’s major brands include Winston, Camel, LD, and Mevius in the tobacco sector. It has a presence in Japan, France, Germany, Italy, the Philippines, Taiwan, Jordan, Kazakhstan, and Romania. JT Group is headquartered in Minato-ku, Tokyo, Japan.Japan Tobacco Inc Key Recent Developments
- Jul 31, 2025: Japan Tobacco Reports 2025 Second Quarter Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
- DiaSorin SpA Company Overview
- DiaSorin SpA Company Snapshot
- DiaSorin SpA Pipeline Products and Ongoing Clinical Trials Overview
- DiaSorin SpA - Pipeline Analysis Overview
- Business Description
- DiaSorin SpA - Key Facts
- DiaSorin SpA - Major Products and Services
- DiaSorin SpA Pipeline Products by Development Stage
- DiaSorin SpA Pipeline Products Overview
- Automated Antigen Detection Assay
- Automated Antigen Detection Assay Product Overview
- BCR-ABL ABL Assay
- BCR-ABL ABL Assay Product Overview
- BCR-ABL P190 + ABL Assay
- BCR-ABL P190 + ABL Assay Product Overview
- BCR-ABL v1.5 Assay
- BCR-ABL v1.5 Assay Product Overview
- C-Kit 816 Assay
- C-Kit 816 Assay Product Overview
- C-Kit 822 Assay
- C-Kit 822 Assay Product Overview
- Calprotectin 3.0
- Calprotectin 3.0 Product Overview
- Diagnostic Assay - Atypical Pneumonia
- Diagnostic Assay - Atypical Pneumonia Product Overview
- Diagnostic Assay - Atypical Pneumonia
- Diagnostic Assay - Atypical Pneumonia Product Overview
- Diagnostic Assay - Chronic Kidney Disease
- Diagnostic Assay - Chronic Kidney Disease Product Overview
- Diagnostic Assay - Enteric Infection
- Diagnostic Assay - Enteric Infection Product Overview
- Diagnostic Assay - Fecal Occult Blood Assay
- Diagnostic Assay - Fecal Occult Blood Assay Product Overview
- Diagnostic Assay - Group B Streptococcus Infection
- Diagnostic Assay - Group B Streptococcus Infection Product Overview
- Diagnostic Assay - HBsAg High Throughput
- Diagnostic Assay - HBsAg High Throughput Product Overview
- Diagnostic Assay - HCV II
- Diagnostic Assay - HCV II Product Overview
- Diagnostic Assay - HSV M + cntr
- Diagnostic Assay - HSV M + cntr Product Overview
- Diagnostic Assay - Lactoferrin Assay
- Diagnostic Assay - Lactoferrin Assay Product Overview
- Diagnostic Assay - Lipase Assay
- Diagnostic Assay - Lipase Assay Product Overview
- Diagnostic Assay - Mycoplasma Genitalium Infection
- Diagnostic Assay - Mycoplasma Genitalium Infection Product Overview
- Diagnostic Assay - Vaginosis
- Diagnostic Assay - Vaginosis Product Overview
- Diagnostic Assay - Vector Borne Diseases
- Diagnostic Assay - Vector Borne Diseases Product Overview
- Diagnostic Test - HEV IgG
- Diagnostic Test - HEV IgG Product Overview
- Diagnostic Test - HEV IgM
- Diagnostic Test - HEV IgM Product Overview
- Estradiol II Assay
- Estradiol II Assay Product Overview
- H.Influenza B Assay
- H.Influenza B Assay Product Overview
- LAMP CBF-MYH D Assay
- LAMP CBF-MYH D Assay Product Overview
- LAMP CBF-MYH E Assay
- LAMP CBF-MYH E Assay Product Overview
- LAMP VCA IgA Assay
- LAMP VCA IgA Assay Product Overview
- LIAISON - Chlamydia P. IgA Assay
- LIAISON - Chlamydia P. IgA Assay Product Overview
- LIAISON - Chlamydia P. IgG Assay
- LIAISON - Chlamydia P. IgG Assay Product Overview
- LIAISON - High Sclerostin Assay
- LIAISON - High Sclerostin Assay Product Overview
- LIAISON - Hyperphosphate High Bone Turnover Assay
- LIAISON - Hyperphosphate High Bone Turnover Assay Product Overview
- LIAISON - Hyperphosphate Low Bone Turnover Assay
- LIAISON - Hyperphosphate Low Bone Turnover Assay Product Overview
- LIAISON IAM - Acute Lymphoblastic Leukemia Test
- LIAISON IAM - Acute Lymphoblastic Leukemia Test Product Overview
- LIAISON IAM - Acute Promyelocytic Leukemia Test
- LIAISON IAM - Acute Promyelocytic Leukemia Test Product Overview
- LIAISON IAM - EBV Assay
- LIAISON IAM - EBV Assay Product Overview
- LIAISON IAM - Myeloproliferative Neoplasm Assay
- LIAISON IAM - Myeloproliferative Neoplasm Assay Product Overview
- Liaison LymeDetect
- Liaison LymeDetect Product Overview
- LIAISON NES System
- LIAISON NES System Product Overview
- LIAISON NES System - SARS-CoV-2 And Influenza A & B Test
- LIAISON NES System - SARS-CoV-2 And Influenza A & B Test Product Overview
- Liaison Plex - Blood Panel
- Liaison Plex - Blood Panel Product Overview
- LIAISON XL - Chlamydia Pneumoniae Assay
- LIAISON XL - Chlamydia Pneumoniae Assay Product Overview
- LIAISON XL - Parvovirus B19 Test
- LIAISON XL - Parvovirus B19 Test Product Overview
- LIAISON XL- Procalcitonin Assay
- LIAISON XL- Procalcitonin Assay Product Overview
- Neisseria Meningitidis Assay
- Neisseria Meningitidis Assay Product Overview
- PML-RAR1 + ABL Assay
- PML-RAR1 + ABL Assay Product Overview
- PML-RAR2 + ABL Assay
- PML-RAR2 + ABL Assay Product Overview
- PML-RAR3 + ABL Assay
- PML-RAR3 + ABL Assay Product Overview
- Progesterone II Assay
- Progesterone II Assay Product Overview
- Quant ABL Assay
- Quant ABL Assay Product Overview
- Quant BCR-ABL p210 Assay
- Quant BCR-ABL p210 Assay Product Overview
- Reagent ASRs - Gastro-Intestinal Infections
- Reagent ASRs - Gastro-Intestinal Infections Product Overview
- Reagent ASRs - Genetic Disorders
- Reagent ASRs - Genetic Disorders Product Overview
- Reagent ASRs - Immuno-Compromised Disorders
- Reagent ASRs - Immuno-Compromised Disorders Product Overview
- Reagent ASRs - Infectious Disease
- Reagent ASRs - Infectious Disease Product Overview
- Reagent ASRs - Respiratory Disease
- Reagent ASRs - Respiratory Disease Product Overview
- Reagent ASRs - Vector-Borne Disease
- Reagent ASRs - Vector-Borne Disease Product Overview
- DiaSorin SpA - Key Competitors
- DiaSorin SpA - Key Employees
- DiaSorin SpA - Key Employee Biographies
- DiaSorin SpA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- DiaSorin SpA, Recent Developments
- Jun 15, 2026: DiaSorin Receives 510(k) Clearance for LIAISON XL Analyzer
- May 20, 2026: Diasorin Board of Directors Approves the 2026-2030 Business Plan
- May 19, 2026: Diasorin Receives 510(K) Clearance for Fully Customizable Liaison Plex Gastrointestinal Flex Assay
- May 19, 2026: DiaSorin Obtains Pre-Market Approval (PMA) For LIAISON Biotrin Control Parvovirus B19 IgM Plus
- May 19, 2026: DiaSorin Obtains Pre-Market Approval (PMA) For LIAISON Biotrin Parvovirus B19 IgM Plus Assay
- Mar 19, 2026: Diasorin Signs Strategic Distribution Agreement with MCKESSON Medical Surgical to Expand Access for the Liaison NES Molecular Point-Of-Care Platform and the Flu A/B, RSV & COVID-19 Panel in Non-Acute Settings Across the United States
- Feb 24, 2026: Diasorin Introduces Next-Generation Liaison Quantiferon-Tb Gold Plus II Assay For the U.S. In Partnership With Qiagen
- Dec 28, 2025: Diasorin Receives FDA 510(K) Clearance and Clia-Waiver for Its First Assay, the 4-Plex Respiratory Panel, on the Liason NES Molecular Diagnostics Platform
- Nov 24, 2025: Diasorin Submits the Liaison Plex Gastrointestinal Flex Assay ToThe U.S. FDA for 510(K) Clearan
- Oct 22, 2025: Diasorin Signs a Supplier Agreement With Quest Diagnostics for the Innovative Molecular Multiplexing Platform, Liaison Plex
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- DiaSorin SpA Pipeline Products and Ongoing Clinical Trials Overview
- DiaSorin SpA Pipeline Products by Equipment Type
- DiaSorin SpA Pipeline Products by Indication
- DiaSorin SpA, Key Facts
- DiaSorin SpA, Major Products and Services
- DiaSorin SpA Number of Pipeline Products by Development Stage
- DiaSorin SpA Pipeline Products Summary by Development Stage
- Automated Antigen Detection Assay - Product Status
- Automated Antigen Detection Assay - Product Description
- BCR-ABL ABL Assay - Product Status
- BCR-ABL ABL Assay - Product Description
- BCR-ABL P190 + ABL Assay - Product Status
- BCR-ABL P190 + ABL Assay - Product Description
- BCR-ABL v1.5 Assay - Product Status
- BCR-ABL v1.5 Assay - Product Description
- C-Kit 816 Assay - Product Status
- C-Kit 816 Assay - Product Description
- C-Kit 822 Assay - Product Status
- C-Kit 822 Assay - Product Description
- Calprotectin 3.0 - Product Status
- Calprotectin 3.0 - Product Description
- Diagnostic Assay - Atypical Pneumonia - Product Status
- Diagnostic Assay - Atypical Pneumonia - Product Description
- Diagnostic Assay - Atypical Pneumonia - Product Status
- Diagnostic Assay - Atypical Pneumonia - Product Description
- Diagnostic Assay - Chronic Kidney Disease - Product Status
- Diagnostic Assay - Chronic Kidney Disease - Product Description
- Diagnostic Assay - Enteric Infection - Product Status
- Diagnostic Assay - Enteric Infection - Product Description
- Diagnostic Assay - Fecal Occult Blood Assay - Product Status
- Diagnostic Assay - Fecal Occult Blood Assay - Product Description
- Diagnostic Assay - Group B Streptococcus Infection - Product Status
- Diagnostic Assay - Group B Streptococcus Infection - Product Description
- Diagnostic Assay - HBsAg High Throughput - Product Status
- Diagnostic Assay - HBsAg High Throughput - Product Description
- Diagnostic Assay - HCV II - Product Status
- Diagnostic Assay - HCV II - Product Description
- Diagnostic Assay - HSV M + cntr - Product Status
- Diagnostic Assay - HSV M + cntr - Product Description
- Diagnostic Assay - Lactoferrin Assay - Product Status
- Diagnostic Assay - Lactoferrin Assay - Product Description
- Diagnostic Assay - Lipase Assay - Product Status
- Diagnostic Assay - Lipase Assay - Product Description
- Diagnostic Assay - Mycoplasma Genitalium Infection - Product Status
- Diagnostic Assay - Mycoplasma Genitalium Infection - Product Description
- Diagnostic Assay - Vaginosis - Product Status
- Diagnostic Assay - Vaginosis - Product Description
- Diagnostic Assay - Vector Borne Diseases - Product Status
- Diagnostic Assay - Vector Borne Diseases - Product Description
- Diagnostic Test - HEV IgG - Product Status
- Diagnostic Test - HEV IgG - Product Description
- Diagnostic Test - HEV IgM - Product Status
- Diagnostic Test - HEV IgM - Product Description
- Estradiol II Assay - Product Status
- Estradiol II Assay - Product Description
- H.Influenza B Assay - Product Status
- H.Influenza B Assay - Product Description
- LAMP CBF-MYH D Assay - Product Status
- LAMP CBF-MYH D Assay - Product Description
- LAMP CBF-MYH E Assay - Product Status
- LAMP CBF-MYH E Assay - Product Description
- LAMP VCA IgA Assay - Product Status
- LAMP VCA IgA Assay - Product Description
- LIAISON - Chlamydia P. IgA Assay - Product Status
- LIAISON - Chlamydia P. IgA Assay - Product Description
- LIAISON - Chlamydia P. IgG Assay - Product Status
- LIAISON - Chlamydia P. IgG Assay - Product Description
- LIAISON - High Sclerostin Assay - Product Status
- LIAISON - High Sclerostin Assay - Product Description
- LIAISON - Hyperphosphate High Bone Turnover Assay - Product Status
- LIAISON - Hyperphosphate High Bone Turnover Assay - Product Description
- LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Status
- LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Description
- LIAISON IAM - Acute Lymphoblastic Leukemia Test - Product Status
- LIAISON IAM - Acute Lymphoblastic Leukemia Test - Product Description
- LIAISON IAM - Acute Promyelocytic Leukemia Test - Product Status
- LIAISON IAM - Acute Promyelocytic Leukemia Test - Product Description
- LIAISON IAM - EBV Assay - Product Status
- LIAISON IAM - EBV Assay - Product Description
- LIAISON IAM - Myeloproliferative Neoplasm Assay - Product Status
- LIAISON IAM - Myeloproliferative Neoplasm Assay - Product Description
- Liaison LymeDetect - Product Status
- Liaison LymeDetect - Product Description
- LIAISON NES System - Product Status
- LIAISON NES System - Product Description
- LIAISON NES System - SARS-CoV-2 And Influenza A & B Test - Product Status
- LIAISON NES System - SARS-CoV-2 And Influenza A & B Test - Product Description
- Liaison Plex - Blood Panel - Product Status
- Liaison Plex - Blood Panel - Product Description
- LIAISON XL - Chlamydia Pneumoniae Assay - Product Status
- LIAISON XL - Chlamydia Pneumoniae Assay - Product Description
- LIAISON XL - Parvovirus B19 Test - Product Status
- LIAISON XL - Parvovirus B19 Test - Product Description
- LIAISON XL- Procalcitonin Assay - Product Status
- LIAISON XL- Procalcitonin Assay - Product Description
- Neisseria Meningitidis Assay - Product Status
- Neisseria Meningitidis Assay - Product Description
- PML-RAR1 + ABL Assay - Product Status
- PML-RAR1 + ABL Assay - Product Description
- PML-RAR2 + ABL Assay - Product Status
- PML-RAR2 + ABL Assay - Product Description
- PML-RAR3 + ABL Assay - Product Status
- PML-RAR3 + ABL Assay - Product Description
- Progesterone II Assay - Product Status
- Progesterone II Assay - Product Description
- Quant ABL Assay - Product Status
- Quant ABL Assay - Product Description
- Quant BCR-ABL p210 Assay - Product Status
- Quant BCR-ABL p210 Assay - Product Description
- Reagent ASRs - Gastro-Intestinal Infections - Product Status
- Reagent ASRs - Gastro-Intestinal Infections - Product Description
- Reagent ASRs - Genetic Disorders - Product Status
- Reagent ASRs - Genetic Disorders - Product Description
- Reagent ASRs - Immuno-Compromised Disorders - Product Status
- Reagent ASRs - Immuno-Compromised Disorders - Product Description
- Reagent ASRs - Infectious Disease - Product Status
- Reagent ASRs - Infectious Disease - Product Description
- Reagent ASRs - Respiratory Disease - Product Status
- Reagent ASRs - Respiratory Disease - Product Description
- Reagent ASRs - Vector-Borne Disease - Product Status
- Reagent ASRs - Vector-Borne Disease - Product Description
- DiaSorin SpA, Key Employees
- DiaSorin SpA, Key Employee Biographies
- DiaSorin SpA, Subsidiaries
- Glossary
- DiaSorin SpA Pipeline Products by Equipment Type
- DiaSorin SpA Pipeline Products by Development Stage
